Cargando…
Molecular mechanisms of chemoresistance in osteosarcoma (Review)
Due to the emergence of adjuvant and neoadjuvant chemotherapy, the survival rate has been greatly improved in osteosarcoma (OS) patients with localized disease. However, this survival rate has remained unchanged over the past 30 years, and the long-term survival rate for OS patients with metastatic...
Autores principales: | HE, HONGTAO, NI, JIANGDONG, HUANG, JUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997672/ https://www.ncbi.nlm.nih.gov/pubmed/24765137 http://dx.doi.org/10.3892/ol.2014.1935 |
Ejemplares similares
-
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
por: Song, Bo, et al.
Publicado: (2010) -
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016) -
GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance
por: Kim, Mihwa, et al.
Publicado: (2018) -
Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
por: Yu, Lei, et al.
Publicado: (2022) -
The molecular mechanisms of chemoresistance in cancers
por: Zheng, Hua-Chuan
Publicado: (2017)